Beta-adrenoceptor blocking drugs, heart rate and genetic hypertension development in rats
- PMID: 36293
- DOI: 10.1007/BF01960381
Beta-adrenoceptor blocking drugs, heart rate and genetic hypertension development in rats
Abstract
In spontaneously hypertensive rats (SHRs) chronically treated during their growth with beta-adrenoceptor blocking drugs, no correlation was found between the reduction in heart rate and the prevention of genetic hypertension development.
Similar articles
-
Comparison of the anti-hypertensive response to beta-adrenoceptor blocking drugs in intact and adrenal-demedullated spontaneously hypertensive rats.Br J Pharmacol. 1980 Apr;68(4):667-76. doi: 10.1111/j.1476-5381.1980.tb10859.x. Br J Pharmacol. 1980. PMID: 6103721 Free PMC article.
-
[Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].Nihon Yakurigaku Zasshi. 1983 Aug;82(2):103-16. Nihon Yakurigaku Zasshi. 1983. PMID: 6198264 Japanese.
-
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.Am J Med. 1976 Nov;61(5):779-89. doi: 10.1016/0002-9343(76)90159-5. Am J Med. 1976. PMID: 10729
-
Indications for beta-adrenoceptor blocking drugs in hypertension.Postgrad Med J. 1976;52 Suppl 4:81-5. Postgrad Med J. 1976. PMID: 9635 Review.
-
Hypertension, beta-adrenoceptor blocking agents and exercise.Int J Sports Med. 1994 Apr;15(3):112-5. doi: 10.1055/s-2007-1021030. Int J Sports Med. 1994. PMID: 7911791 Review.